BusinessWorld covers findings suggesting GLP-1 drugs such as Wegovy could lower the risk of certain cancers. Details on which ones are in the full story.
Recap by typeshit. Full story at BusinessWorld Online.
In mice, GLP-1 receptor signaling mainly calmed inflammation while GLP-2 receptor signaling helped the intestine repair after T cell attack, researchers report.
Talker Research polled 2,000 Americans for aesthetics company Revance. Of 1,402 GLP-1 users, over 24% reported a new identity shift after starting the drugs.
Raw numbers pointed to higher AMD risk with GLP-1 drugs, but researchers say the pattern reversed once heart and metabolic factors were accounted for.
The Havre de Grace center opened a research building and will test whether the pairing cuts alcohol cravings. The study starts in early 2027, results about two years later.
A social post says semaglutide and tirzepatide affect appetite, fullness and blood sugar, not only weight. A general explainer from a health account.
Clinical pharmacy specialist Emily Van Klompenburg walks through the ways GLP-1 drugs are taken and how the options stack up against each other.
Loading…